Modulation of the immune response toward allografts in vivo.  I.  Selective suppression of the development of cell-mediated immunity by soluble alloantigens.
D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D001667:Binding, Competitive; D002462:Cell Membrane / Q000276:immunology; D002860:Chromium Radioisotopes; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D012995:Solubility; D013154:Spleen / Q000166:cytology; D014184:Transplantation, Homologous
D002860:Chromium Radioisotopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D003165:Complement System Proteins